We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Lab Reports |

New Mutations May Develop in Recurrent Tumors

Tracy Hampton, PhD
JAMA. 2014;311(5):456. doi:10.1001/jama.2014.26.
Text Size: A A A
Published online


Recurrent tumors often develop a set of genetic mutations that are markedly different from the original tumor, reports an international group of scientists who analyzed the genomes of 23 low-grade gliomas and recurrences of those malignancies (Johnson BE et al. Science. 2014;343[6167]:189-193).

In 43% of cases, at least half of the mutations in the initial tumor were undetected at recurrence. The investigators also found that recurrent tumors from patients who were treated with temozolomide, an alkylating agent that inhibits DNA replication, were hypermutated compared with recurrent gliomas from patients not treated with temozolomide. Many of the mutations occurred in genes involved with the RB and AKT-mTOR cell signaling pathways, which are associated with high-grade gliomas and are known cancer drivers.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Low-grade regions (blue/green) of a brain tumor mass, reflecting the original tumor, and .high-grade regions (yellow/red), reflecting recurrent disease, may have markedly different mutations.

Sarah J. Nelson, PhD/University of California, San Francisco



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles